InsidersTradesSigma
TL
TLX Stock: price and directors' dealings · Australia · ASX
Track the TLX stock price and the full directors' dealings record of the company, a listed equity based in Australia. Shares trade on AU AU, under the supervision of ASX. Operating in the Healthcare & Pharma sector, TLX has logged 9 insider filings. Market capitalisation: €5.5bn. The latest transaction was disclosed on 30 June 2026 (Initial Substantial Holding). Among the most active insiders: Unknown. Every trade is free.
9
Insider Decl.
0
Thresholds
€607,982
2 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate TLX Strong Buy (bullish), based on 12 analysts. Average price target: A$23.35.
26Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 20,576 of 26,092 companies
31.5
score / 100
Value32
Quality31
FCF yld-1.1%
Earn yld-0.1%
EV/EBITDA·
ROE-1.9%
Gross mgn53%
Net mgn-0.9%
Debt/EBITDA13.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 30 June 2026
Declarations9 total
ShareASXASX:2924-03097995-3A694873
ShareASXASX:2924-03089990-3A693283
ShareASXASX:2924-03089979-3A693279
ShareASXASX:2924-03089977-3A693278
67,935 shares@ A$14.67140.016% mcap100.0% of flowShareASXASX:2924-03084212-3A692242
Ideal exit: 24 Jan 2027 (T+270)
ShareASXASX:2924-03083454-3A692125
9 of 9 declarations
About TLX
TLX is a company in the healthcare and pharmaceutical sector, listed on the XASX. It focuses on developing innovative solutions to enhance healthcare.
